The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital.

CEO Steven Gourlay, joins The Market Online to discuss the company’s development.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

ACW by the numbers
More From The Market Online

Provaris Energy’s hydrogen tanker fabrication to recommence; shares up 6%

Provaris (ASX:PV1) has announced fabrication of its prototype hydrogen tanker is to recommence in 2025, pushing…
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Market Update Graphic

ASX Market Update: Index sheds another 1% as Discretionary stocks lead broad selloff | December 20, 2024

The ASX200 has been down 1% at 8,084 points.
A rubbish truck dumping landfill

‘Meaningful step towards our target’: Cleanaway JV opens door to monetising landfill gas

Cleanaway Waste Management has entered a joint venture with LMS Energy Pty Ltd to enable landfill…